PRESIDENT HAS SERVED AS A REVIEWER FOR THE ZRG1 BST-H (50) PAR-16-390 ‘NIBIB Trailblazer Award for New and Early Stage Investigators’ (R21) STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the ZRG1 BST-H (50) PAR-16-390 ‘NIBIB Trailblazer Award for New and Early Stage Investigators’ (R21) Study Section for the National Institute of Health (NIH) held on June 28, 2017.

pdx news

  • President presents at the 2018 International Academy of Oral Medicine and Toxicology (IAOMT) Symposium

    9/21/2018
    read more

  • President serves as chair for the 2018 Nanomedicine and Drug Delivery Symposium (NANODDS)

    9/21/2018
    read more

  • PDX Pharma met phase I SBIR milestones and is approved for starting the phase II SBIR project by the National Cancer Institute on 06/01/2018

    5/25/2018
    read more

Copyright © 2017 PDX Pharmaceuticals, LLC. All rights reserved